Most Clicked StoriesMore >


Report: Stem-cell injections result in permanent eye damage in 3 women

AABB SmartBrief | Mar 20, 2017

Three women who paid $5,000 each for stem-cell injections to treat macular degeneration suffered permanent eye damage, with one woman becoming completely blind, according to a report in The New England Journal of Medicine. The unproven treatment was undertaken at a private clinic in Florida, where technicians injected the women's eyes with stem cells extracted from their own belly fat. The New York Times (free-article access for SmartBrief readers) (03/15)


5 women with erroneous Zika test results from D.C. lab give birth

AABB SmartBrief | Mar 20, 2017

AABB to host eCast on blood center diversification

AABB SmartBrief | Mar 17, 2017

New drugs increase hepatitis C cure rate among veterans

AABB SmartBrief | Mar 16, 2017

Gene therapy method uses microbubbles to treat hemophilia in mice

AABB SmartBrief | Mar 15, 2017

Biomarker of liver damage may persist after hepatitis C treatment

AABB SmartBrief | Mar 20, 2017

AABB to host eCast on expanded use of donor lymphocyte infusion

AABB SmartBrief | Mar 20, 2017

Allogenic stem cell transplant shows positive result in early-stage trial

AABB SmartBrief | Mar 16, 2017

WHO: Travelers to areas of Brazil should get yellow fever vaccination

AABB SmartBrief | Mar 21, 2017

Merck's blood cancer drug receives FDA approval

AABB SmartBrief | Mar 15, 2017


Find AABB SmartBrief Issues by Date:



AABB News More >


PEP mentoring program seeking a few good mentors and mentees

AABB SmartBrief | Mar 22, 2017

Reminder: Applications due March 31 for "Transfusion" editor-in-chief

AABB SmartBrief | Mar 21, 2017

AABB to host eCast on expanded use of donor lymphocyte infusion

AABB SmartBrief | Mar 20, 2017

AABB to host eCast on blood center diversification

AABB SmartBrief | Mar 17, 2017

Support NBF's early career scientific research grants program

AABB SmartBrief | Mar 16, 2017




Sign up for AABB SmartBrief



Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Learn more